Monte Rosa Therapeutics (GLUE)
Develops molecular glue degrader medicines across oncology, immunology, and inflammation.
$11.75
vs last close−0.85 (−6.75%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
in 43 days
EPS estimate
−$0.23
Revenue estimate
$31.1M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$0.23$0.57−$0.15−$0.33−$0.54−$0.45−$0.43Pending
Estimate$0.02$0.00−$0.38−$0.37−$0.35−$0.28−$0.38−$0.23
Surprise+1,379.1%—+60.2%+9.9%−53.6%−60.7%−13.0%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$60.6M$84.9M$23.2M$12.8M$2.8M$4.2M$9.0MPending
Estimate$46.7M$13.6M$7.8M$15.5M$15.6M$11.0M$12.9M$31.1M
Surprise+30.0%+526.0%+198.4%−17.7%−82.0%−61.7%−30.3%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.63 | — | — |
| Sep 2027 | −$0.61 | — | — |
| Jun 2027 | −$0.61 | — | — |
| Mar 2027 | −$0.58 | — | — |
| Dec 2026 | −$0.38 | — | — |
| Nov 2026 | −$0.23 | — | — |
| Aug 2026 | −$0.38 | −$0.43 | −13.0% |
| May 2026 | −$0.28 | −$0.45 | −60.7% |
| Mar 2026 | −$0.35 | −$0.54 | −53.6% |
| Nov 2025 | −$0.37 | −$0.33 | +9.9% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| Jun 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.63 | — | — | $5.0M | — | — | — |
| Sep 2027 | −$0.61 | — | — | $5.0M | — | — | — |
| Jun 2027 | −$0.61 | — | — | $3.9M | — | — | — |
| Mar 2027 | −$0.58 | — | — | $3.9M | — | — | — |
| Dec 2026 | −$0.38 | — | — | $21.6M | — | — | — |
| Nov 5, 2026 | −$0.23 | — | — | $31.1M | — | — | — |
| Aug 6, 2026 | −$0.38 | −$0.43 | −13.0% | $12.9M | $9.0M | −30.3% | +0.6% |
| May 7, 2026 | −$0.28 | −$0.45 | −60.7% | $11.0M | $4.2M | −61.7% | −2.8% |
| Mar 17, 2026 | −$0.35 | −$0.54 | −53.6% | $15.6M | $2.8M | −82.0% | −2.0% |
| Nov 6, 2025 | −$0.37 | −$0.33 | +9.9% | $15.5M | $12.8M | −17.7% | +5.7% |
| Aug 7, 2025 | |||||||
| May 8, 2025 | |||||||
| Mar 20, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 9, 2024 | |||||||
| Mar 14, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 16, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 11, 2022 | |||||||
| Mar 29, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Aug 12, 2021 | |||||||
| Jun 25, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 |